Gerontology/Geriatrics Topic Homepage

Learning Zones

,Prostate Cancer Learning Hub

Prostate cancer is the third most frequently diagnosed cancer in Europe and the most common cancer among European men,1 making it a major cause of morbidity. Risk factors for prostate cancer include, increasing age, genetic susceptibility, glucose intolerance and environmental factors.2

The Prostate Cancer Learning Hub has been designed with the busy healthcare professional in mind. The resource conveniently organises a range of up-to-date education content, reference materials and decision support tools, all focussing on prostate cancer.

The disease awareness section provides you with access to a Prostate Cancer Knowledge Centre, which has been developed to provide you with easy to digest best practice guidance for the treatment and management of patients with prostate cancer. In addition access to editorials of key journal publications, an events calendar, video channel, patient materials and interactive healthcare professionals tools are also available.


  1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374-1403. EUCAN fact sheet. Estimated incidence, mortality & prevalence, 2012.
  2. Tewari R, Rajender S, Natu SM et al. Diet, obesity, and prostate health: are we missing the link? J Androl 2012;33:763-776.



The Anti-Coagulation Video Channel* is intended for primary care practitioners and specialists involved in the treatment and follow up care of patients with atrial fibrillation (AF) or venous thromboembolism (VTE). It provides an overview of how to prevent stroke and systemic embolism in nonvalvular AF patients and how to prevent and treat VTE.

Users can expect to find the following videos readily available on the video channel with regular updates:

  • Atrial fibrillation and ischaemic stroke (Hans-Christoph Diener)
  • How do novel oral anticoagulants change stroke prevention in atrial fibrillation? (Gregory YH Lip and A John Camm)
  • The anti-coagulation debate: would routine monitoring alter patient outcomes? (Jeffrey Weitz and Harry R Büller)

Healthcare professionals should return often to avoid missing out on new content.

*The Anti-Coagulation Video Channel has been supported by an educational grant from Boehringer Ingelheim, and is intended for healthcare professionals outside the USA, Canada and UK.

,COPD Knowledge Centre

Patients with Chronic Obstructive Pulmonary Disease (COPD) will rank as the fifth leading cause of disability in 2030, accounting for almost 4% of total disability-adjusted life years (DALYs) lost worldwide.1 Many patients with COPD report that the symptoms of COPD are at their worst in the morning, having a major impact on their quality of life.2,3 For this reason effective management of morning symptoms has to be a major treatment goal.

The COPD Knowledge Centre has been designed to provide you, as a healthcare professionals, with free access to educational disease awareness. This includes information on the epidemiology, pathophysiology, and symptoms of COPD and the latest best practice guidelines for the diagnosis, treatment and management for the disease.

COPD specific resources such as videos, guidelines, infographics, materials for your patients, upcoming events and useful websites are available for you. In addition educational slide decks and an interactive presentation from ATS 2013 are also available.


  1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and prevention of COPD. 2014
  2. Partridge MR, Karlsson N, Small IR. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin 2009;25: 2043-2048. 
  3. Partridge MR et al. Curr Med Res Opin 2012;28:1405. [Erratum].

The Anti-Infectives Knowledge Network – Clostridium difficile infection (AIKN-CDI), an initiative by Astellas Pharma EMEA, shares the expertise and experience of thought leaders in the area of anti-infectives.

Recent content updates include:

Please remember to return often to read updated news, clinical insights, and essential information from the latest congresses.


This educational resource is sponsored by Astellas Pharma EMEA and assembles the expertise of key thinkers in the area of anti-infectives with a focus on invasive fungal infections.

Ensure you return often to make the most of regular updates to this resource including congress highlights, industry reports, policy changes, clinical guidelines and downloadable materials (e.g. presentation slides) from major medical events.

Latest update:

The congresses section has been updated with a report from the ‘Integrating Critical Care and Haemato-oncology’ meeting held in Berlin, November 2014. Experts gathered to share opinion and debate on the changing nature of care for haemato-oncology patients requiring critical care. View this report for free here.

August 2015 MYC/15/0023/EUa

Latest News

Medical Videos

Ask The Geriatrician - The Physiology of Ageing
Ask The Geriatrician - The Physiology of Ageing

Recent Drug Updates

Medical Journal Abstracts on Gerontology/Geriatrics

Amantadine in Parkinson's disease.

8 days ago -  Amantadine in Parkinson's disease.

BACKGROUND: Although levodopa is the most common drug prescribed to relieve the symptoms of Parkinson's disease it is associated with motor and psychiatric side-effects. Consequently, interest ...

Pharmacological treatment of Parkinson disease: a review.

8 days ago -  Pharmacological treatment of Parkinson disease: a review.

IMPORTANCE: Parkinson disease is the second most common neurodegenerative disease worldwide. Although no available therapies alter the underlying neurodegenerative process, symptomatic therapies ...

Clinical Guidelines

European Stroke Organisation (ESO) guidelines for the management of temperature in patients with acute ischemic stroke

Jul 2015

Hyperthermia is a frequent complication in up to 50% of patients with acute ischemic stroke, and it..

... was shown to be associated with a poor outcome. On the other end, therapeutically induced hypothermia has shown promising potential in patients with hypoxic encephalopathy and in animal models of focal cerebral ischemia. This document presents the ESO guidelines on temperature management in patients with acute ischemic stroke. The aim of this Guideline document is to assist physicians treating patients with acute ischemic stroke in their clinical decisions with regard to the management of temperature.

Lower urinary tract symptoms: The management of lower urinary tract symptoms in men

Jun 2015

Lower urinary tract symptoms (LUTS) in men are best categorised into voiding, storage or..

... post-micturition symptoms to help define the source of the problem. Voiding symptoms include weak or intermittent urinary stream, straining, hesitancy, terminal dribbling and incomplete emptying. Storage symptoms include urgency, frequency, urgency incontinence and nocturia. The major post-micturition symptom is post-micturition dribbling, which is common and bothersome. Although LUTS do not usually cause severe illness, they can considerably reduce men's quality of life, and may point to serious pathology of the urogenital tract.

LUTS are a major burden for the ageing male population. Age is an important risk factor for LUTS and the prevalence of LUTS increases as men get older. Bothersome LUTS can occur in up to 30% of men older than 65 years. This is a large group potentially requiring treatment.

Because uncertainty and variation exist in clinical practice, this guideline gives clear recommendations on diagnosing, monitoring and treating LUTS.

Online CME

e-LfH Dementia

Dementia is becoming increasingly prevalent, both due to our ageing population and improved recognition of the condition. However, the nature of dementia means that managing the condition can pose unique...

Anaemia in old age: common presentations

After completing this module you should know how to: take a history and examine an elderly patient with anaemia, diagnose the common causes of anaemia in old age, and treat...

Clinical Trials

221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease (EMERGE)

Wed 01 Jul 2015

The primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia ...

A Phase 3 Study to Examine the Efficacy, Safety and Tolerability of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease

Mon 01 Jun 2015

A 12-week, prospective, multi-center, randomized, double-blind, placebo controlled, Phase 3 study in L-Dopa responsive PD patients with motor fluctuations ("OFF" episodes), designed to ...

Back to top